Cardiovascular Clinical Trial - AMGEN - Evolve MI

Cardiovascular

Status:

Open to accrual

ClinicalTrials.gov:

NCT05284747

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

Drug

Evolocumab, Routine Lipid Management

Phase

VI

Condition

Cardiovascular Disease, Myocardial Infarction, Stroke, Coronary Revascularization